Trial Profile
Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Risperidone (Primary) ; Ziprasidone (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics; Pharmacogenomic
- 21 Nov 2016 New trial record